Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers, Susanne Famulla, Nina Wronkowitz, et al.
Diabetes (2011) Vol. 60, Iss. 7, pp. 1917-1925
Open Access | Times Cited: 559

Showing 26-50 of 559 citing articles:

Post-acute sequelae of COVID-19: A metabolic perspective
Philipp E. Scherer, John P. Kirwan, Clifford J. Rosen
eLife (2022) Vol. 11
Open Access | Times Cited: 76
Adipose Dipeptidyl Peptidase-4 and Obesity
Henrike Sell, Matthias Blüher, Nora Klöting, et al.
Diabetes Care (2013) Vol. 36, Iss. 12, pp. 4083-4090
Open Access | Times Cited: 200
The role of adipokines in β-cell failure of type 2 diabetes
Simon Dunmore, James E. Brown
Journal of Endocrinology (2012) Vol. 216, Iss. 1, pp. T37-T45
Open Access | Times Cited: 195
Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells
Silja Raschke, Kristin Eckardt, Kirsten B. Holven, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e62008-e62008
Open Access | Times Cited: 191
Clinical Relevance of Adipokines
Matthias Blüher
Diabetes & Metabolism Journal (2012) Vol. 36, Iss. 5, pp. 317-317
Open Access | Times Cited: 189
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró
Mediators of Inflammation (2013) Vol. 2013, pp. 1-15
Open Access | Times Cited: 179
DPP4 in Cardiometabolic Disease
Jixin Zhong, Andrei Maiseyeu, Stephen N. Davis, et al.
Circulation Research (2015) Vol. 116, Iss. 8, pp. 1491-1504
Open Access | Times Cited: 166
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, et al.
Endocrinology (2013) Vol. 154, Iss. 3, pp. 1260-1270
Open Access | Times Cited: 163
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
Young Min Cho, Yukihiro Fujita, Timothy J. Kieffer
Annual Review of Physiology (2013) Vol. 76, Iss. 1, pp. 535-559
Open Access | Times Cited: 162
Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions
Toshimasa Shigeta, Morihiko Aoyama, Yoshiyuki Bando, et al.
Circulation (2012) Vol. 126, Iss. 15, pp. 1838-1851
Open Access | Times Cited: 159
Targeting inflammation in diabetes: Newer therapeutic options
Neeraj Agrawal, S. Kant
World Journal of Diabetes (2014) Vol. 5, Iss. 5, pp. 697-697
Open Access | Times Cited: 159
Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
Yuji Ishibashi, Takanori Matsui, Sayaka Maeda, et al.
Cardiovascular Diabetology (2013) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Adipose Organ Development and Remodeling
Saverio Cinti
Comprehensive physiology (2018), pp. 1357-1431
Open Access | Times Cited: 155
Targeting fatty acid metabolism to improve glucose metabolism
Rudi Stinkens, Gijs H. Goossens, Johan W. E. Jocken, et al.
Obesity Reviews (2015) Vol. 16, Iss. 9, pp. 715-757
Closed Access | Times Cited: 154
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Angelo Avogaro, Gian Paolo Fadini
Diabetes Care (2014) Vol. 37, Iss. 10, pp. 2884-2894
Open Access | Times Cited: 148
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
Gábor Firneisz
PubMed (2014) Vol. 20, Iss. 27, pp. 9072-89
Closed Access | Times Cited: 139
CD26/DPP4 - a potential biomarker and target for cancer therapy
Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester, et al.
Pharmacology & Therapeutics (2019) Vol. 198, pp. 135-159
Open Access | Times Cited: 139
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Nina Wronkowitz, Sven W. Görgens, Tania Romacho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 9, pp. 1613-1621
Open Access | Times Cited: 138
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier, Luisa Schlüter, Sophie Saussenthaler, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 10, pp. 1254-1263
Open Access | Times Cited: 131
Adipose Tissue Dysfunction and Impaired Metabolic Health in Human Obesity: A Matter of Oxygen?
Gijs H. Goossens, Ellen E. Blaak
Frontiers in Endocrinology (2015) Vol. 6
Open Access | Times Cited: 130
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
Andreas Ritter, Nina‐Naomi Kreis, Frank Louwen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5793-5793
Open Access | Times Cited: 128
Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up‐regulated by hypoxia in human adipocytes and smooth muscle cells
Diana Röhrborn, Jürgen Eckel, Henrike Sell
FEBS Letters (2014) Vol. 588, Iss. 21, pp. 3870-3877
Open Access | Times Cited: 127
Islet inflammation: a unifying target for diabetes treatment?
Yumi Imai, Anca D. Dobrian, Margaret A. Morris, et al.
Trends in Endocrinology and Metabolism (2013) Vol. 24, Iss. 7, pp. 351-360
Open Access | Times Cited: 120
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
Elodie M. Varin, Erin E. Mulvihill, Jacqueline L. Beaudry, et al.
Cell Metabolism (2018) Vol. 29, Iss. 2, pp. 320-334.e5
Open Access | Times Cited: 119
Blood-Brain Barriers in Obesity
Elizabeth M. Rhea, Therese S. Salameh, Aric F. Logsdon, et al.
The AAPS Journal (2017) Vol. 19, Iss. 4, pp. 921-930
Open Access | Times Cited: 117

Scroll to top